Noxopharm Ltd has released a press release.
Establishment of Nyrada Inc.
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from Noxopharm
- Positive Clinical Outcomes for NOX66 at ESMO Conference
- Important Brain Cancer Findings for NOX66 Program
- Reinstatement to Official Quotation
- Noxopharm raises $5.5 million to advance clinical program
- Suspension from Official Quotation
Later from Noxopharm
- Australian NOX66 - Radiotherapy Study Opens
- UNSW collaboration confirms drug designed for stroke victims
- 1st Patient treated in Lupin Study at St Vincents Hospital
- Promising Interim Clinical Data for NOX66
- Clarification of Incorrect Information
Follow Noxopharm into a list and get an email when it puts out news.
Follow Noxopharm